Cargando…
MicroRNA-130b functions as an oncomiRNA in non-small cell lung cancer by targeting tissue inhibitor of metalloproteinase-2
Non-small cell lung cancer (NSCLC) is the most frequent cause of cancer-related death worldwide. Although many molecular-targeted drugs for NSCLC have been developed in recent years, the 5-year survival rate of patients with NSCLC remains low. Therefore, an improved understanding of the molecular me...
Autores principales: | Hirono, Takayuki, Jingushi, Kentaro, Nagata, Toshiyuki, Sato, Masami, Minami, Kentaro, Aoki, Masaya, Takeda, Aya Harada, Umehara, Tadashi, Egawa, Hiroshi, Nakatsuji, Yoshino, Kitae, Kaori, Ueda, Yuko, Hase, Hiroaki, Yamamoto, Masatatsu, Shinsato, Yoshinari, Kawahara, Kohichi, Furukawa, Tatsuhiko, Tsujikawa, Kazutake |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502853/ https://www.ncbi.nlm.nih.gov/pubmed/31061410 http://dx.doi.org/10.1038/s41598-019-43355-8 |
Ejemplares similares
-
Pharmacological Inhibition of miR-130 Family Suppresses Bladder Tumor Growth by Targeting Various Oncogenic Pathways via PTPN1
por: Monoe, Yuya, et al.
Publicado: (2021) -
The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN
por: Egawa, Hiroshi, et al.
Publicado: (2016) -
HDAC inhibitor misprocesses bantam oncomiRNA, but stimulates hid induced apoptotic pathway
por: Bhadra, Utpal, et al.
Publicado: (2015) -
Liquid Biopsy-Based Exo-oncomiRNAs Can Predict Prostate Cancer Aggressiveness
por: Ruiz-Plazas, Xavier, et al.
Publicado: (2021) -
ALKBH4 promotes tumourigenesis with a poor prognosis in non-small-cell lung cancer
por: Jingushi, Kentaro, et al.
Publicado: (2021)